🚀 VC round data is live in beta, check it out!
Medline Valuation Multiples
Discover revenue and EBITDA valuation multiples for Medline and similar public comparables like Fresenius, Mindray, Steris, Becton Dickinson and more.
Medline Overview
About Medline
Medline Inc is a medical-surgical products and supply chain solutions provider in the USA. The company has two reportable segments, Medline Brand and Supply Chain Solutions, the combination of which addresses critical needs in the market through a comprehensive solution. The product portfolio of the company includes 335,000 med-surg products, including surgical and procedural kits, gloves and protective apparel, urological and incontinence care, wound care, and consumable lab and diagnostics products. The company generates its maximum revenue domestically and serves some of the key USA health systems.
Founded
2024
HQ
Employees
45.0K
Website
Sectors
Financials (FY)
EV
$53B
Medline Financials
Medline reported last fiscal year revenue of $28B and EBITDA of $3B.
In the same fiscal year, Medline generated $8B in gross profit, $3B in EBITDA, and $2B in net income.
Revenue (LTM)
Medline P&L
In the most recent fiscal year, Medline reported revenue of $28B and EBITDA of $3B.
Medline expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $28B | XXX | XXX | XXX |
| Gross Profit | — | XXX | $8B | XXX | XXX | XXX |
| Gross Margin | — | XXX | 26% | XXX | XXX | XXX |
| EBITDA | — | XXX | $3B | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 11% | XXX | XXX | XXX |
| Net Profit | — | XXX | $2B | XXX | XXX | XXX |
| Net Margin | — | XXX | 6% | XXX | XXX | XXX |
| Net Debt | — | — | $11B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Medline Stock Performance
Medline has current market cap of $37B, and enterprise value of $53B.
Market Cap Evolution
Medline's stock price is $45.92.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $53B | $37B | 0.0% | XXX | XXX | XXX | $2.11 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMedline Valuation Multiples
Medline trades at 1.9x EV/Revenue multiple, and 15.3x EV/EBITDA.
EV / Revenue (LTM)
Medline Financial Valuation Multiples
As of March 28, 2026, Medline has market cap of $37B and EV of $53B.
Equity research analysts estimate Medline's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Medline has a P/E ratio of 21.7x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $37B | XXX | $37B | XXX | XXX | XXX |
| EV (current) | $53B | XXX | $53B | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 1.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 15.3x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 16.7x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 7.0x | XXX | XXX | XXX |
| P/E | — | XXX | 21.7x | XXX | XXX | XXX |
| EV/FCF | — | XXX | 40.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Medline Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Medline Margins & Growth Rates
Medline's revenue in the last fiscal year grew by 9%.
Medline Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 9% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 3% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 19% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Medline Public Comps
See public comps and valuation multiples for other Medical Supplies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Fresenius | XXX | XXX | XXX | XXX | XXX | XXX |
| Mindray | XXX | XXX | XXX | XXX | XXX | XXX |
| Steris | XXX | XXX | XXX | XXX | XXX | XXX |
| Becton Dickinson | XXX | XXX | XXX | XXX | XXX | XXX |
| Terumo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Medline M&A Activity
Medline acquired XXX companies to date.
Last acquisition by Medline was on XXXXXXXX, XXXXX. Medline acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Medline
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialMedline Investment Activity
Medline invested in XXX companies to date.
Medline made its latest investment on XXXXXXXX, XXXXX. Medline invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Medline
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Medline
| When was Medline founded? | Medline was founded in 2024. |
| Where is Medline headquartered? | Medline is headquartered in United States. |
| How many employees does Medline have? | As of today, Medline has over 45K employees. |
| Is Medline publicly listed? | Yes, Medline is a public company listed on Nasdaq. |
| What is the stock symbol of Medline? | Medline trades under MDLN ticker. |
| When did Medline go public? | Medline went public in 2025. |
| Who are competitors of Medline? | Medline main competitors are Fresenius, Mindray, Steris, Becton Dickinson. |
| What is the current market cap of Medline? | Medline's current market cap is $37B. |
| What is the current revenue of Medline? | Medline's last fiscal year revenue is $28B. |
| What is the current revenue growth of Medline? | Medline revenue growth (vs. last FY) is 9%. |
| What is the current EV/Revenue multiple of Medline? | Current revenue multiple of Medline is 1.9x. |
| Is Medline profitable? | No, Medline is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.